Drug for treating polycystic ovarian syndrome

Abstract

The invention relates to a drug for treating polycystic ovarian syndrome. The drug is characterized by comprising an oral medicine and an enema medicine, wherein the oral medicine comprises 15 g of common curculigo rhizome, 10 g of epimedium, 15 g of common cnidium fruit, 15 g of medicinal morinda root, 15 g of dodder, 15 g of glossy privet fruit, 15 g of medlar, 10 g of prepared rhizome of rehmannia, 15 g of angelica, 15 g of szechwan lovage rhizome, 15 g of salvia miltiorrhiza, 15 g of dangshen, 15 g of stir-fried ovate atractylodes root, 15 g of tuckahoe, 30 g of common yam rhizome, 15 g of pinellia, 12 g of seasoned orange peel, and 15 g of officinal magnolia bark, and the enema medicine comprises 15 g of peach seed, 10 g of safflower, 15 g of common burreed tuber, 12 g of cassiabarktree twig, 15 g of trumpetweed, 15 g of speranskia tuberculata, 15 g of common selfheal spike, 15 g of Chinese honeylocust spine, 15 g of szechwan lovage rhizome, 15 g of seaweed, and 15 g of kelp. According to the present invention, treatment philosophy of combination of the oral medicine and the enema medicine is adopted, and blood circulation activating, blood stasis dissipating, swelling subsiding, and stagnation eliminating are adopted to reduce intumescent ovary and thin ovarian follicle, such that ovulation easily occurs.

Description

technical field [0001] The invention relates to a Chinese herbal medicine and its administration method, in particular to a medicine for treating polycystic ovary syndrome with good curative effect and no side effect. Background technique [0002] As we all know, polycystic ovary syndrome is a relatively common endocrine and metabolic disorder in adolescents and women of childbearing age, and its incidence is about 5%-10%. and insulin resistance. It is a special disease that coexists with reproductive dysfunction and abnormal glucose metabolism. The main clinical manifestations are late menstruation, amenorrhea, infertility, ovarian enlargement and other reproductive dysfunction and metabolic abnormalities such as obesity, acne and hirsutism. Because the mechanism of its occurrence and development is still unclear, it is really a difficult disease in clinical practice. [0003] Modern medical treatment of polycystic ovary syndrome mainly uses anti-androgen (commonly used ...

AI Technical Summary

Problems solved by technology

[0003] Modern medical treatment of polycystic ovary syndrome mainly uses anti-androgen (commonly used Diane 35) and artificial cycle of sex hormones and improves insulin sensitivity (metformin) treatment, while traditional Chinese medicine gynecology often only uses kidney and spleen, blood circulation and menstruation treatment Although these methods are effective, they still have many disadvantages: many patients suffer from sensitivity to the side effects of the above-mentioned drugs and find it difficult to adhere to a sufficient course of treatment; What is more important is that the simple hormone regimen or the simple use of traditional Chinese medicine for oral administration, the clinical effect is indeed unsatisfactory, so it is called a difficult disease